These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36561844)

  • 1. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer.
    Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J
    Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated transcriptome meta-analysis of pancreatic ductal adenocarcinoma and matched adjacent pancreatic tissues.
    Atay S
    PeerJ; 2020; 8():e10141. PubMed ID: 33194391
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Jiao Y; Li Y; Liu S; Chen Q; Liu Y
    Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833
    [No Abstract]   [Full Text] [Related]  

  • 4. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
    Li Q; Ma W; Chen S; Tian EC; Wei S; Fan RR; Wang T; Zhou C; Li T
    Transl Lung Cancer Res; 2020 Aug; 9(4):1361-1378. PubMed ID: 32953510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancreatic Cancer Cells.
    Liu M; Zhang Y; Yang J; Cui X; Zhou Z; Zhan H; Ding K; Tian X; Yang Z; Fung KA; Edil BH; Postier RG; Bronze MS; Fernandez-Zapico ME; Stemmler MP; Brabletz T; Li YP; Houchen CW; Li M
    Gastroenterology; 2020 Feb; 158(3):679-692.e1. PubMed ID: 31711924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of anti-tumor
    Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
    Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of ITGA3 as an Oncogene in Human Tongue Cancer via Integrated Bioinformatics Analysis.
    Chen WL; Wang XK; Wu W
    Curr Med Sci; 2018 Aug; 38(4):714-720. PubMed ID: 30128883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer.
    Ma JJ; Xiang C; Zhu HQ; Bai BL; Wang P; Zhao GA
    Heliyon; 2024 Jan; 10(1):e23163. PubMed ID: 38163190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 10.
    Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
    Front Oncol; 2021; 11():658547. PubMed ID: 34094951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ITGA3 acts as a purity-independent biomarker of both immunotherapy and chemotherapy resistance in pancreatic cancer: bioinformatics and experimental analysis.
    Zheng X; Du Y; Liu M; Wang C
    Funct Integr Genomics; 2023 Jun; 23(2):196. PubMed ID: 37270717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential hub genes associated with the pathogenesis and prognosis of pancreatic duct adenocarcinoma using bioinformatics meta-analysis of multi-platform datasets.
    Ma Y; Pu Y; Peng L; Luo X; Xu J; Peng Y; Tang X
    Oncol Lett; 2019 Dec; 18(6):6741-6751. PubMed ID: 31807183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Analysis of an Invasion-Related 3-Gene Signature and Its Validation as a Prognostic Model for Pancreatic Cancer.
    Xu D; Wang Y; Zhang Y; Liu Z; Chen Y; Zheng J
    Front Oncol; 2021; 11():759586. PubMed ID: 34976806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer.
    Kurozumi A; Goto Y; Matsushita R; Fukumoto I; Kato M; Nishikawa R; Sakamoto S; Enokida H; Nakagawa M; Ichikawa T; Seki N
    Cancer Sci; 2016 Jan; 107(1):84-94. PubMed ID: 26509963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
    Wang JR; Liu B; Zhou L; Huang YX
    Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

  • 17. Transmembrane Protein 170B is a Prognostic Biomarker and Associated With Immune Infiltrates in Pancreatic Adenocarcinoma.
    Zhang Z; Shang J; Dai Z; Yao Y; Shi Y; Zhong D; Liang Y; Lai C; Yang Q; Feng T; Huang X
    Front Genet; 2022; 13():848391. PubMed ID: 35601487
    [No Abstract]   [Full Text] [Related]  

  • 18. Identifying
    Ding J; Liu Y; Lai Y
    PeerJ; 2020; 8():e10419. PubMed ID: 33282565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel candidate biomarkers for pancreatic adenocarcinoma based on TCGA cohort.
    Jie Y; Peng W; Li YY
    Aging (Albany NY); 2021 Feb; 13(4):5698-5717. PubMed ID: 33591944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
    Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
    BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.